We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$12.2B
AUM Growth
+$822M
(+7.2%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
1,100
New
46
Increased
577
Reduced
433
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.9M |
| 2 |
Vanguard Value ETF
VTV
|
+$19.9M |
| 3 |
Virtu Financial
VIRT
|
+$18M |
| 4 |
Alcon
ALC
|
+$18M |
| 5 |
Procter & Gamble
PG
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ecolab
ECL
|
+$22.6M |
| 2 |
Clorox
CLX
|
+$15.2M |
| 3 |
Rithm Capital
RITM
|
+$9.88M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$8.85M |
| 5 |
State Street
STT
|
+$8.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Financials | 15.41% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
676
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.74M | 0.02% |
27,640
+5,057
| +22% | +$483K |
|
|
PCH
677
DELISTED
PotlatchDeltic
PCH
| $2.74M | 0.02% |
+70,295
| New | +$2.64M |
|
678
DNOW Inc
DNOW
$2.63B
| $2.74M | 0.02% |
185,494
+5,371
| +3% | +$76.8K |
|
|
DNKN
679
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $2.71M | 0.02% |
33,993
-5,869
| -15% | -$446K |
|
680
Banco Santander
SAN
$194B
| $2.71M | 0.02% |
616,540
+5,892
| +1% | +$26.5K |
|
681
L3Harris
LHX
$55.9B
| $2.69M | 0.02% |
14,229
-748
| -5% | -$135K |
|
|
JBTM
682
JBT Marel
JBTM
$7.14B
| $2.68M | 0.02% |
22,120
-518
| -2% | -$55.7K |
|
683
First American
FAF
$7.67B
| $2.66M | 0.02% |
49,559
-392
| -0.8% | -$21.3K |
|
684
NiSource
NI
$22.4B
| $2.65M | 0.02% |
92,051
+3,540
| +4% | +$99.7K |
|
685
Kinder Morgan
KMI
$73.1B
| $2.65M | 0.02% |
126,847
+29,930
| +31% | +$604K |
|
686
Supernus Pharmaceuticals
SUPN
$2.68B
| $2.64M | 0.02% |
+79,877
| New | +$2.74M |
|
687
RPM International
RPM
$13.7B
| $2.64M | 0.02% |
43,209
+1,121
| +3% | +$66.2K |
|
|
DOOR
688
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.64M | 0.02% |
50,104
-8,975
| -15% | -$464K |
|
689
SouthState Bank Corp
SSB
$10.3B
| $2.63M | 0.02% |
35,683
-1,517
| -4% | -$109K |
|
690
Qualys
QLYS
$4.84B
| $2.61M | 0.02% |
29,978
+11,680
| +64% | +$1.01M |
|
|
ESGR
691
DELISTED
Enstar Group
ESGR
| $2.61M | 0.02% |
14,972
+3,043
| +26% | +$528K |
|
692
Generac Holdings
GNRC
$11.9B
| $2.6M | 0.02% |
37,488
+24,608
| +191% | +$1.44M |
|
693
Royal Caribbean
RCL
$78.7B
| $2.6M | 0.02% |
21,423
+4,200
| +24% | +$512K |
|
694
Enterprise Products Partners
EPD
$83.8B
| $2.6M | 0.02% |
+89,923
| New | +$2.59M |
|
695
Genpact
G
$5.3B
| $2.58M | 0.02% |
67,877
+16,673
| +33% | +$606K |
|
696
News Corp Class B
NWS
$16.4B
| $2.58M | 0.02% |
184,831
-6,988
| -4% | -$86.9K |
|
697
Parker-Hannifin
PH
$125B
| $2.57M | 0.02% |
15,120
+1,669
| +12% | +$288K |
|
698
Ingevity
NGVT
$2.55B
| $2.57M | 0.02% |
24,439
-1,011
| -4% | -$102K |
|
699
SLM Corp
SLM
$4.57B
| $2.57M | 0.02% |
264,099
-21,390
| -7% | -$212K |
|
700
West Pharmaceutical
WST
$23.1B
| $2.56M | 0.02% |
20,500
-1,375
| -6% | -$162K |
|
Similar funds
Natixis Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Natixis Advisors held 1,100 positions worth $12.2B, up 7.2% from $11.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors's Q2 2019 filing shows 46 new, 577 increased, 433 reduced and 42 closed positions. Its largest new stake was Alcon: 306,725 shares worth $19M. The largest sale was Ecolab, an estimated $22.6M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Natixis Advisors's largest Q2 2019 buy was Alcon: 306,725 shares worth $19M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q2 2019, an estimated $28.9M increase.
- Natixis Advisors's biggest Q2 2019 reduction was Ecolab, cutting an estimated $22.6M.
- Natixis Advisors fully exited Clorox in Q2 2019, selling an estimated $15.2M.
- Natixis Advisors's ten largest holdings make up 15% of its $12.2B portfolio in Q2 2019.
- Natixis Advisors opened 46 new positions and closed 42 in Q2 2019.
- Natixis Advisors's portfolio value rose 7.2% quarter-over-quarter to $12.2B.
Based on Natixis Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.